Omega Healthcare Investors, Inc. $OHI Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 77.9% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 3,417,240 shares of the real estate investment trust’s stock after acquiring an additional 1,496,059 shares during the period. JPMorgan Chase & Co.’s holdings in Omega Healthcare Investors were worth $144,278,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Omega Healthcare Investors by 29.4% during the 1st quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock valued at $5,496,000 after acquiring an additional 32,798 shares during the period. Focus Partners Wealth boosted its position in Omega Healthcare Investors by 3.1% during the first quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock worth $756,000 after purchasing an additional 597 shares in the last quarter. Sivia Capital Partners LLC acquired a new stake in Omega Healthcare Investors in the second quarter valued at approximately $257,000. DekaBank Deutsche Girozentrale increased its position in shares of Omega Healthcare Investors by 2.3% in the second quarter. DekaBank Deutsche Girozentrale now owns 58,580 shares of the real estate investment trust’s stock valued at $2,172,000 after buying an additional 1,291 shares in the last quarter. Finally, Securian Asset Management Inc. raised its stake in shares of Omega Healthcare Investors by 3.0% during the 2nd quarter. Securian Asset Management Inc. now owns 22,039 shares of the real estate investment trust’s stock worth $808,000 after buying an additional 634 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI opened at $46.55 on Friday. The firm has a 50-day simple moving average of $44.69 and a 200-day simple moving average of $43.20. The company has a quick ratio of 5.04, a current ratio of 5.04 and a debt-to-equity ratio of 0.78. The stock has a market capitalization of $13.76 billion, a price-to-earnings ratio of 24.12, a price-to-earnings-growth ratio of 1.50 and a beta of 0.57. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $47.94.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Monday, February 9th were issued a $0.67 dividend. The ex-dividend date was Monday, February 9th. This represents a $2.68 dividend on an annualized basis and a yield of 5.8%. Omega Healthcare Investors’s dividend payout ratio is presently 138.86%.

Analysts Set New Price Targets

OHI has been the topic of a number of research analyst reports. UBS Group reissued a “buy” rating and issued a $52.00 price target on shares of Omega Healthcare Investors in a research note on Friday, February 6th. The Goldman Sachs Group initiated coverage on shares of Omega Healthcare Investors in a report on Friday, January 9th. They set a “buy” rating and a $54.00 price objective on the stock. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the company a “hold” rating in a research report on Monday, December 1st. Wells Fargo & Company downgraded shares of Omega Healthcare Investors from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $48.00 to $45.00 in a research report on Thursday, January 29th. Finally, Cantor Fitzgerald raised their price target on shares of Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and a consensus price target of $47.36.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.